Redeye provides a more indepth take on Episurf Medical’s Q3 report. At this point, we emphasise that quarterly sales are not a key metric. Rather, we look at the order intake and customer base growth, which is developing nicely. We will shortly return with a case review update following the company’s new, US focused, strategy.

Read more and download the Research Update.

Follow companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/

© Modular Finance, source Nordic Press Releases